Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tracy A. Klein, Julia A. Dilley, Janessa M. Graves & Erica L. Liebelt. (2022) Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016–2019. Clinical Toxicology 60:9, pages 1024-1028.
Read now
Read now
Articles from other publishers (26)
Jeanna M. Marraffa. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
993
996
.
Stephen Trobbiani, Peter Stockham & Chris Kostakis. (2023) A method for the sensitive targeted screening of synthetic cannabinoids and opioids in whole blood by LC-QTOF-MS with simultaneous suspect screening using HighResNPS.com. Journal of Analytical Toxicology.
Crossref
Crossref
Giorgia Corli, Micaela Tirri, Sabrine Bilel, Arianna Giorgetti, Tatiana Bernardi, Federica Boccuto, Martina Borsari, Raffaele Giorgetti & Matteo Marti. (2023) Ethanol enhances JWH-018-induced impairment of sensorimotor and memory functions in mice: From preclinical evidence to forensic implication in Driving Under the Influence of Drugs. Drug and Alcohol Dependence 247, pages 109888.
Crossref
Crossref
K. Dobšíková, D. Spálovská, M. Kuchař, N. Paškanová & V. Setnička. (2023) Indazole-derived synthetic cannabinoids: Absolute configuration determination and structure characterization by circular dichroism and DFT calculations. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 291, pages 122373.
Crossref
Crossref
Jianbing Wu, Fan Zhang, Xing Ke, Wei Jia, Xuzhi Wan, Lange Zhang, Yilei Fan & Jing Zhou. (2023) Rapid Simultaneous Determination of 11 Synthetic Cannabinoids in Urine by Liquid Chromatography-Triple Quadrupole Mass Spectrometry. Separations 10:3, pages 203.
Crossref
Crossref
Nadja Walle, Adrian A. Doerr, Peter H. Schmidt & Nadine Schaefer. (2022) ‘Flying high?’—Jump from a height in a ‘Spice’ high?: A case report on the synthetic cannabinoid 5F‐MDMB‐P7AICA. Drug Testing and Analysis 15:3, pages 368-373.
Crossref
Crossref
Ziteng Wang, Ching Yee Fong, Evelyn Mei Ling Goh, Hooi Yan Moy & Eric Chun Yong Chan. (2022) Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol. Journal of Analytical Toxicology 46:9, pages 1016-1024.
Crossref
Crossref
Bogdan Tokarczyk, Marta Suchan & Piotr Adamowicz. (2022) New Synthetic Cannabinoid ADB-BUTINACA-Related Death of a Police Dog. Journal of Analytical Toxicology.
Crossref
Crossref
Bogdan Tokarczyk, Agnieszka Jurczyk, Justyna Krupińska & Piotr Adamowicz. (2022) Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA—parent compounds and metabolite identification in blood, urine and cerebrospinal fluid. Forensic Science, Medicine and Pathology 18:4, pages 393-402.
Crossref
Crossref
Amanda L A Mohr, Barry K Logan, Melissa F Fogarty, Alex J Krotulski, Donna M Papsun, Sherri L Kacinko, Marilyn A Huestis & Jeri D Ropero-Miller. (2022) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review. Journal of Analytical Toxicology 46:6, pages e116-e185.
Crossref
Crossref
Jack Markham, Eric Sparkes, Rochelle Boyd, Shuli Chen, Jamie J. Manning, David Finlay, Felcia Lai, Eila McGregor, Callan J. Maloney, Roy R. Gerona, Mark Connor, Iain S. McGregor, David E. Hibbs, Michelle Glass, Richard C. Kevin & Samuel D. Banister. (2022)
Defining Steric Requirements at CB
1
and CB
2
Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues
. ACS Chemical Neuroscience 13:8, pages 1281-1295.
Crossref
Crossref
Michael B. Gatch, Andrew Tourigny, Ritu A. Shetty & Michael J. Forster. (2021) Behavioral pharmacology of five novel synthetic cannabinoids. Behavioural Pharmacology 33:2&3, pages 175-183.
Crossref
Crossref
Utku Limon & BetülIlkay Sezgin Akçay. (2022) Hypertensive choroidopathy with bilateral multiple ink blot fluorescein leakage similar to acute central serous chorioretinopathy in a patient using synthetic cannabinoids (Bonzai). Indian Journal of Ophthalmology - Case Reports 2:2, pages 437.
Crossref
Crossref
Olwen Groth, Simon Franz, Helena Fels, Julia Krueger, Gabriele Roider, Torsten Dame, Frank Musshoff & Matthias Graw. (2021) Unexpected results found in larvae samples from two postmortem forensic cases. Forensic Toxicology 40:1, pages 144-155.
Crossref
Crossref
Tanja M. Gampfer, Lea Wagmann, Anouar Belkacemi, Veit Flockerzi & Markus R. Meyer. (2021) Cytotoxicity, metabolism, and isozyme mapping of the synthetic cannabinoids JWH-200, A-796260, and 5F-EMB-PINACA studied by means of in vitro systems. Archives of Toxicology 95:11, pages 3539-3557.
Crossref
Crossref
Jamie J. Manning, Hayley M. Green, Michelle Glass & David B. Finlay. (2021) Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias. Neuropharmacology 193, pages 108611.
Crossref
Crossref
Phoebe Sharp, Simon Hudson & Stephen R. Morley. (2021) Quantitation of Synthetic Cannabinoid Receptor Agonists in Postmortem Blood Using a Single Point Calibration. Academic Forensic Pathology 11:2, pages 75-82.
Crossref
Crossref
F. Ivy Carroll, Anita H. Lewin, S. Wayne Mascarella, Herbert H. Seltzman & P. Anantha Reddy. (2020) Designer drugs: a medicinal chemistry perspective (II). Annals of the New York Academy of Sciences 1489:1, pages 48-77.
Crossref
Crossref
Carolina Lobato-Freitas, Andreia Machado Brito-da-Costa, Ricardo Jorge Dinis-Oliveira, Helena Carmo, Félix Carvalho, João Pedro Silva & Diana Dias-da-Silva. (2021) Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications. Pharmaceuticals 14:3, pages 186.
Crossref
Crossref
Brandon C. Presley, Marisol S. Castaneto, Barry K. Logan & Susan A. Jansen‐Varnum. (2020) Assessment of synthetic cannabinoid FUB‐AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC–MS/MS. Biomedical Chromatography 34:9.
Crossref
Crossref
Paul L Morrow, Simon Stables, Kilak Kesha, Rexson Tse, Diana Kappatos, Rishi Pandey, Sarah Russell, Oliver Linsell, Mary Jane McCarthy, Amy Spark, Dianne Vertes, Yvonne Triggs, Sinead McCarthy, Nanise Cuthers & Richard Massey. (2020) An outbreak of deaths associated with AMB-FUBINACA in Auckland NZ. EClinicalMedicine 25, pages 100460.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Ryan M. Alam & John J. Keating. (2020) Adding more “spice” to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists. Drug Testing and Analysis 12:3, pages 297-315.
Crossref
Crossref
Rui Shen Ong, Diana C. Kappatos, Sarah G.G. Russell, Helen A. Poulsen, Samuel D. Banister, Roy R. Gerona, Michelle Glass, Cameron S. Johnson & Mary‐Jane McCarthy. (2019) Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography–tandem mass spectrometry – A New Zealand perspective of use in 2018. Drug Testing and Analysis 12:2, pages 195-214.
Crossref
Crossref
David B. Finlay, Jamie J. Manning, Mikkel Søes Ibsen, Christa E. Macdonald, Monica Patel, Jonathan A. Javitch, Samuel D. Banister & Michelle Glass. (2019) Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA. ACS Chemical Neuroscience 10:10, pages 4350-4360.
Crossref
Crossref
Dimmito, Stefanucci, Pieretti, Minosi, Dvorácskó, Tömböly, Zengin & Mollica. (2019) Discovery of Orexant and Anorexant Agents with Indazole Scaffold Endowed with Peripheral Antiedema Activity. Biomolecules 9:9, pages 492.
Crossref
Crossref